rs623022

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_006946.4(SPTBN2):​c.5340C>T​(p.Asn1780Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0544 in 1,612,232 control chromosomes in the GnomAD database, including 3,060 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.050 ( 322 hom., cov: 32)
Exomes 𝑓: 0.055 ( 2738 hom. )

Consequence

SPTBN2
NM_006946.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.113
Variant links:
Genes affected
SPTBN2 (HGNC:11276): (spectrin beta, non-erythrocytic 2) Spectrins are principle components of a cell's membrane-cytoskeleton and are composed of two alpha and two beta spectrin subunits. The protein encoded by this gene (SPTBN2), is called spectrin beta non-erythrocytic 2 or beta-III spectrin. It is related to, but distinct from, the beta-II spectrin gene which is also known as spectrin beta non-erythrocytic 1 (SPTBN1). SPTBN2 regulates the glutamate signaling pathway by stabilizing the glutamate transporter EAAT4 at the surface of the plasma membrane. Mutations in this gene cause a form of spinocerebellar ataxia, SCA5, that is characterized by neurodegeneration, progressive locomotor incoordination, dysarthria, and uncoordinated eye movements. [provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 11-66691509-G-A is Benign according to our data. Variant chr11-66691509-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 305547.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66691509-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.113 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SPTBN2NM_006946.4 linkuse as main transcriptc.5340C>T p.Asn1780Asn synonymous_variant 27/38 ENST00000533211.6 NP_008877.2 O15020-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SPTBN2ENST00000533211.6 linkuse as main transcriptc.5340C>T p.Asn1780Asn synonymous_variant 27/385 NM_006946.4 ENSP00000432568.1 O15020-1

Frequencies

GnomAD3 genomes
AF:
0.0498
AC:
7586
AN:
152214
Hom.:
316
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00965
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0533
Gnomad ASJ
AF:
0.0248
Gnomad EAS
AF:
0.113
Gnomad SAS
AF:
0.0743
Gnomad FIN
AF:
0.146
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0541
Gnomad OTH
AF:
0.0463
GnomAD3 exomes
AF:
0.0644
AC:
16051
AN:
249430
Hom.:
717
AF XY:
0.0644
AC XY:
8699
AN XY:
135182
show subpopulations
Gnomad AFR exome
AF:
0.00849
Gnomad AMR exome
AF:
0.0544
Gnomad ASJ exome
AF:
0.0250
Gnomad EAS exome
AF:
0.112
Gnomad SAS exome
AF:
0.0696
Gnomad FIN exome
AF:
0.137
Gnomad NFE exome
AF:
0.0566
Gnomad OTH exome
AF:
0.0639
GnomAD4 exome
AF:
0.0548
AC:
80029
AN:
1459900
Hom.:
2738
Cov.:
34
AF XY:
0.0553
AC XY:
40198
AN XY:
726446
show subpopulations
Gnomad4 AFR exome
AF:
0.00789
Gnomad4 AMR exome
AF:
0.0549
Gnomad4 ASJ exome
AF:
0.0263
Gnomad4 EAS exome
AF:
0.107
Gnomad4 SAS exome
AF:
0.0664
Gnomad4 FIN exome
AF:
0.135
Gnomad4 NFE exome
AF:
0.0506
Gnomad4 OTH exome
AF:
0.0545
GnomAD4 genome
AF:
0.0499
AC:
7603
AN:
152332
Hom.:
322
Cov.:
32
AF XY:
0.0539
AC XY:
4017
AN XY:
74484
show subpopulations
Gnomad4 AFR
AF:
0.00965
Gnomad4 AMR
AF:
0.0542
Gnomad4 ASJ
AF:
0.0248
Gnomad4 EAS
AF:
0.114
Gnomad4 SAS
AF:
0.0752
Gnomad4 FIN
AF:
0.146
Gnomad4 NFE
AF:
0.0542
Gnomad4 OTH
AF:
0.0444
Alfa
AF:
0.0465
Hom.:
127
Bravo
AF:
0.0403
Asia WGS
AF:
0.123
AC:
427
AN:
3478
EpiCase
AF:
0.0446
EpiControl
AF:
0.0443

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxApr 13, 2021- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
SPTBN2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJul 08, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJul 12, 2017- -
Autosomal dominant cerebellar ataxia Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.40
CADD
Benign
6.8
DANN
Benign
0.83
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs623022; hg19: chr11-66458980; COSMIC: COSV59460873; COSMIC: COSV59460873; API